U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H24O5
Molecular Weight 320.3802
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of .ALPHA.-ZEARALENOL

SMILES

C[C@H]1CCC[C@H](O)CCC\C=C\C2=CC(O)=CC(O)=C2C(=O)O1

InChI

InChIKey=FPQFYIAXQDXNOR-QDKLYSGJSA-N
InChI=1S/C18H24O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h3,7,10-12,14,19-21H,2,4-6,8-9H2,1H3/b7-3+/t12-,14+/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H24O5
Molecular Weight 320.3802
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/21889607

Zearalenone (ZEN) is a well-known mycotoxin present in numerous agricultural products. Humans and animals are therefore at a risk of exposure to zearalenone through consumption of contaminated food. After intake, ZEN is reduced to α- and β-zearalenol (α-ZEL and β-ZEL), zearalanone (ZAN), and α- and β-zearalanol (α-ZAL and β-ZAL). Zearalenone and its metabolites, including Alpha-zearalenol are full agonists for hERα and possess hAR-mediated antagonistic activity in PALM cells. Zearalenone and its derivatives have been shown to be carcinogenic, immunotoxic, and hepatonephrotoxic.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.06 nM [EC50]
4.17 µM [IC50]
Target ID: P05106
Gene ID: 3690.0
Gene Symbol: ITGB3
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Activation of ER stress and apoptosis by α- and β-zearalenol in HCT116 cells, protective role of Quercetin.
2016-03
Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
2015-02
Assessment of estrogenic and anti-androgenic activities of the mycotoxin zearalenone and its metabolites using in vitro receptor-specific bioassays.
2014-12
Selectivity of natural, synthetic and environmental estrogens for zebrafish estrogen receptors.
2014-10-01
Affinity purification using recombinant PXR as a tool to characterize environmental ligands.
2014-02
Cellular mechanisms of the cytotoxic effects of the zearalenone metabolites α-zearalenol and β-zearalenol on RAW264.7 macrophages.
2013-04
Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities.
2012-11-19
Catechol metabolites of zeranol and 17β-estradiol: a comparative in vitro study on the induction of oxidative DNA damage and methylation by catechol-O-methyltransferase.
2012-04-05
In vitro toxicological effects of estrogenic mycotoxins on human placental cells: structure activity relationships.
2012-03-15
Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
2012-02
Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis.
2011-10-10
Aromatic hydroxylation and catechol formation: a novel metabolic pathway of the growth promotor zeranol.
2010-02-15
ABCC1, ABCC2 and ABCC3 are implicated in the transepithelial transport of the myco-estrogen zearalenone and its major metabolites.
2009-10-28
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types.
2004-07
Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta.
2004-01
Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
2003-10
Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.
2003-06
Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods.
2001-05
Differential estrogen receptor binding of estrogenic substances: a species comparison.
2000-11-15
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
One umol/L, 0.1 umol/L and 10 nmol/L alpha-zearalenol inhibited angiotensin II-stimulated Integrin β3 mRNA expression in HUVECs
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:22:31 GMT 2025
Edited
by admin
on Mon Mar 31 19:22:31 GMT 2025
Record UNII
59D4EVJ5KC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
.ALPHA.-ZEARALENOL
Common Name English
6-(10-HYDROXY-6-OXO-TRANS-1-UNDECENYL)-.BETA.-RESORCYLIC ACID P-LACTONE
Preferred Name English
ZEARALENOL
Common Name English
3,4,5,6,7,8,9,10-OCTAHYDRO-7,14,16-TRIHYDROXY-3-METHYL-1H-2-BENZOXACYCLOTETRADECIN-1-ONE
Systematic Name English
1H-2-BENZOXACYCLOTETRADECIN-1-ONE, 3,4,5,6,7,8,9,10-OCTAHYDRO-7,14,16-TRIHYDROXY-3-METHYL-
Systematic Name English
1H-2-BENZOXACYCLOTETRADECIN-1-ONE, 3,4,5,6,7,8,9,10-OCTAHYDRO-7,14,16-TRIHYDROXY-3-METHYL-, (3S,7R,11E)-
Systematic Name English
Code System Code Type Description
CAS
5916-52-9
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
NON-SPECIFIC STOICHIOMETRY
PUBCHEM
5284645
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID8022402
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
PRIMARY
WIKIPEDIA
alpha-Zearalenol
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
PRIMARY
MESH
C029659
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
PRIMARY
CAS
36455-72-8
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
PRIMARY
FDA UNII
59D4EVJ5KC
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
PRIMARY
SMS_ID
300000052856
Created by admin on Mon Mar 31 19:22:31 GMT 2025 , Edited by admin on Mon Mar 31 19:22:31 GMT 2025
PRIMARY